We manufacture biological tissue products using a proprietary treatment process. Our tissue processing technology cross-links individual fibers of collagenous tissue, ensuring the integrity, strength and flexibility of the finished product.
Cross-linking of collagenous tissue also reduces antigenicity, and therefore retards the degredation of the material.
Benefits of cross-linked collagen:
- Excellent tensile strength
- Durable
- Strong suture retention
- Resists infection
- Handles like autologous tissue
Our technology has a proven history
Our expertise is based on the same tissue engineering technology originally developed for use in a bioprosthetic heart valve. This heart valve has received US-FDA Premarket Approval and has been in clinical use in Europe for more than 20 years. Following this initial application, we have adapted our process for the manufacture of surgical patch material and other devices.
